1-[5-[2-(4-hydroxyphenyl)-1,3-benzoxazol-5-yl]-3-(2-thienyl)-3,4-dihydropyrazol-2-yl]ethanone

ID: ALA5196118

Chembl Id: CHEMBL5196118

PubChem CID: 168288937

Max Phase: Preclinical

Molecular Formula: C22H17N3O3S

Molecular Weight: 403.46

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N1N=C(c2ccc3oc(-c4ccc(O)cc4)nc3c2)CC1c1cccs1

Standard InChI:  InChI=1S/C22H17N3O3S/c1-13(26)25-19(21-3-2-10-29-21)12-17(24-25)15-6-9-20-18(11-15)23-22(28-20)14-4-7-16(27)8-5-14/h2-11,19,27H,12H2,1H3

Standard InChI Key:  WZDUNBGQHZPNHL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5196118

    ---

Associated Targets(non-human)

Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 403.46Molecular Weight (Monoisotopic): 403.0991AlogP: 4.96#Rotatable Bonds: 3
Polar Surface Area: 78.93Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.05CX Basic pKa: CX LogP: 3.88CX LogD: 3.87
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.52Np Likeness Score: -1.51

References

1. Kumar Sahoo S, Maddipatla S, Nageswara Rao Gajula S, Naiyaz Ahmad M, Kaul G, Nanduri S, Sonti R, Dasgupta A, Chopra S, Madhavi Yaddanapudi V..  (2022)  Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy.,  64  [PMID:35487101] [10.1016/j.bmc.2022.116777]
2. Sharma A, De Rosa M, Singla N, Singh G, Barnwal RP, Pandey A..  (2021)  Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant Tuberculosis Strains.,  64  (8.0): [PMID:33826327] [10.1021/acs.jmedchem.0c01833]

Source